|
| 翔宇医疗(688626)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2024-04-01 | 10749.12 | 67.18% | 16000.00 | 0.00 | 5250.88 | 32.82% | 首发原股东限售股份 | | 2023-03-31 | 160.00 | 1.00% | 5250.88 | 10749.12 | 5111.99 | 31.95% | 首发战略配售股份 | | 2022-03-31 | 1250.88 | 7.82% | 5122.86 | 10877.14 | 5122.86 | 32.02% | 首发原股东限售股份 | | 2021-09-30 | 167.10 | 1.04% | 3871.98 | 12128.02 | 3871.98 | 24.20% | 首发机构配售股份 |
|